Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14612536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ionizing radiation-induced Rad51 nuclear focus formation is cell cycle-regulated and defective in both ATM(-/-) and c-Abl(-/-) cells.

  2003cited by this paper
• Perspectives on the development of a molecularly targeted agent.

  2002cited by this paper
• BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability

  2002cited by this paper
• A reverse transcription comparative real-time PCR method for quantitative detection of angiogenic growth factors in head and neck cancer patients.

  2002cited by this paper
• Fusion Tyrosine Kinases Induce Drug Resistance by Stimulation of Homology-Dependent Recombination Repair, Prolongation of G2/M Phase, and Protection from Apoptosis

  2002cited by this paper
• Inhibition of radiation-induced nuclear factor-kappaB activation by an anti-Ras single-chain antibody fragment: lack of involvement in radiosensitization.

  2002cited by this paper
• Elevated levels of Rad51 recombination protein in tumor cells.

  2002cited by this paper
• Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning

  2002cited by this paper
• Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells.

  2001cited by this paper
• BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance.

  2001cited by this paper
• The ABL kinase inhibitor STI571 does not affect survival of hematopoietic cells after ionizing radiation.

  2000cited by this paper
• Radiation-induced Assembly of Rad51 and Rad52 Recombination Complex Requires ATM and c-Abl*

  1999cited by this paper
• Regulation of Rad51 Function by c-Abl in Response to DNA Damage*

  1998cited by this paper
• Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation.

  1998cited by this paper
• Xrcc3 Is Required for Assembly of Rad51 Complexes in Vivo *

  1998cited by this paper
• In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene.

  1998cited by this paper
• Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumors.

  1997influential reference
• Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase.

  1997cited by this paper
• Antisense inhibition of the RAD51 enhances radiosensitivity.

  1996cited by this paper
• A review of human cell radiosensitivity in vitro.

  1996cited by this paper
• Cell cycle-dependent expression of the mouseRad51 gene in proliferating cells

  1996cited by this paper
• Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes.

  1995cited by this paper
• A mouse homolog of the Escherichia coli recA and Saccharomyces cerevisiae RAD51 genes.

  1993cited by this paper
• Nucleotide sequence and transcriptional regulation of the yeast recombinational repair gene RAD51

  1992cited by this paper
• Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein.

  1992cited by this paper
• Mean inactivation dose: a useful concept for intercomparison of human cell survival curves.

  1984cited by this paper

• The CDK12–BRCA1 signaling axis mediates dinaciclib‐associated radiosensitivity through p53‐mediated cellular senescence

  2024cites this paper
• The signalling axis CDK12-BRCA1 mediates dinaciclib associated radiosensitivity through p53-mediated cellular senescence

  2024cites this paper
• The impact of DNA double‐strand break repair pathways throughout the carbon ion spread‐out Bragg peak beam

  2023cites this paper
• Moving the Needle Forward in Genomically-Guided Precision Radiation Treatment

  2023cites this paper
• Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells via Inhibition of RAD51 Expression

  2023cites this paper
• Reparative properties of human glioblastoma cells after single exposure to a wide range of X-ray doses

  2022cites this paper
• Polymorphic Variants in 5'-UTR Regions of the RAD51 Gene are Associated With RAD51 Expression and Triple-Negative Breast Cancer (TNBC): A Case-Control Study.

  2021cites this paper
• Medicine: Therapeutic and Other Applications Using Sealed Radiation Sources

  2021cites this paper
• RAD51-Mediated DNA Homologous Recombination Is Independent of PTEN Mutational Status

  2020cites this paper
• N6-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression

  2020cites this paper
• PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes

  2019cites this paper
• Personalised Medicine

  2019cites this paper
• Evaluating the potential of kinase inhibitors to suppress DNA repair and sensitise ovarian cancer cells to PARP inhibitors.

  2019cites this paper
• Optimization of Drug Candidates That Inhibit the D‐Loop Activity of RAD51

  2019cites this paper
• Activation of the Unfolded Protein Response via Inhibition of Protein Disulfide Isomerase Decreases the Capacity for DNA Repair to Sensitize Glioblastoma to Radiotherapy.

  2019cites this paper
• X-rays Activate Telomeric Homologous Recombination Mediated Repair in Primary Cells

  2019cites this paper
• Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma

  2019cites this paper
• Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets

  2019cites this paper
• DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance

  2019cites this paper
• Cell Cycle Changes after Glioblastoma Stem Cell Irradiation: The Major Role of RAD51

  2018cites this paper
• Analysis of molecular components, causing Fanconi anemia-like phenotype in HPV-16 infected head and neck squamous cell carcinomas

  2017cites this paper
• Silencing platelet-derived growth factor receptor-β enhances the radiosensitivity of C6 glioma cells in vitro and in vivo.

  2017cites this paper
• Integrative genomic analysis identifies ancestry‐related expression quantitative trait loci on DNA polymerase β and supports the association of genetic ancestry with survival disparities in head and neck squamous cell carcinoma

  2017cites this paper
• Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients

  2017cites this paper
• Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy

  2017cites this paper
• Personalised Medicine: Genome Maintenance Lessons Learned from Studies in Yeast as a Model Organism.

  2017cites this paper
• Melanoma cells replicate through chemotherapy by reducing levels of key homologous recombination protein RAD51 and increasing expression of translesion synthesis DNA polymerase ζ

  2017cites this paper
• Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin.

  2017cites this paper
• Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine

  2016cites this paper
• Exploiting DNA Repair and ER Stress Response Pathways to Induce Apoptosis in Glioblastoma Multiforme: A Dissertation

  2016cites this paper
• Cancer TARGETases: DSB repair as a pharmacological target.

  2016cites this paper
• Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?

  2016cites this paper
• Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51.

  2016cites this paper
• A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells

  2016cites this paper
• Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells.

  2016cites this paper
• Regulation of homologous recombinational repair by lamin B1 in radiation‐induced DNA damage

  2015cites this paper
• Therapeutic potential of Rad51 inhibition

  2015influential citation
• Dual and Opposite Effects of hRAD51 Chemical Modulation on HIV-1 Integration.

  2015cites this paper
• Molecularly targeted therapies for recurrent glioblastoma: current and future targets.

  2014cites this paper
• RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization

  2014cites this paper
• Targeting homologous recombination-mediated DNA repair in cancer

  2014cites this paper
• Force et couple dans les pinces magnétiques : paysage énergétique de la protéine hRad51 sur ADN double-brin

  2014cites this paper
• Expression profiling in head and neck cancer: Predicting response to chemoradiation

  2014cites this paper
• Targeting the homologous recombination pathway by small molecule modulators.

  2014cites this paper
• Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure

  2014cites this paper
• Inhibition of c-Abl Kinase Activity Renders Cancer Cells Highly Sensitive to Mitoxantrone

  2014cites this paper
• New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology

  2013cites this paper
• “Synthetic Lethality”: Molecular Co-targeting to Restore the DNA Repair Mechanisms in Prostate Cancer Cells

  2013cites this paper
• p 53 modulates homologous recombination by transcriptional regulation of the RAD 51 gene

  2013cites this paper
• Imatinib radiosensitizes bladder cancer by targeting homologous recombination.

  2013cites this paper
• Network-based approaches for anticancer therapy (Review).

  2013cites this paper
• Enhancing radiation therapy for patients with glioblastoma

  2013cites this paper
• An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity.

  2013cites this paper
• Bortezomib‐induced sensitization of malignant human glioma cells to vorinostat‐induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl‐1 cleavage, and DNA damage

  2013cites this paper
• Inhibition of radiation-induced skin fibrosis with imatinib

  2013cites this paper
• Radiosensitization effects of berberine on human breast cancer cells.

  2012cites this paper
• Detection of Early Abl Kinase Activation after Ionizing Radiation by Using a Peptide Biosensor

  2012cites this paper
• Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.

  2012cites this paper
• Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas

  2012cites this paper
• Evaluation of relation of RAD51 and the effect of chemo-radiation therapy for advanced rectal cancer.

  2012cites this paper
• Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells

  2012cites this paper
• RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells

  2012cites this paper
• DNA Repair and Cell Cycle Biomarkers of Radiation Exposure and Inflammation Stress in Human Blood

  2012cites this paper
• Against Lung Cancer Cells: To Be, or Not to Be, That Is the Problem

  2012cites this paper
• Targeting Homologous Recombination Repair in Cancer

  2012cites this paper
• FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51

  2012cites this paper
• Targeting DNA repair and the cell cycle in glioblastoma

  2012cites this paper
• Suppression of Jab1/CSN5 induces radiation- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways

  2012cites this paper
• Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression

  2012cites this paper
• A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy.

  2012cites this paper
• HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells.

  2012cites this paper
• Effects of Chemotherapeutics on Organotypic Corticostriatal Slice Cultures Identified by A Panel of Fluorescent and Immunohistochemical Markers

  2012influential citation
• Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer

  2011cites this paper
• Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells.

  2011cites this paper
• Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51

  2011cites this paper
• RAD51 as a potential biomarker and therapeutic target for pancreatic cancer.

  2011cites this paper
• Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma

  2011cites this paper
• A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients

  2011cites this paper
• Knockdown of Rad51 expression induces radiation- and chemo-sensitivity in osteosarcoma cells

  2011cites this paper
• The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination.

  2011cites this paper
• Clinical potential of the mTOR targets S 6 K 1 and S 6 K 2 in breast cancer

  2011cites this paper
• The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma

  2011cites this paper
• PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy

  2011cites this paper
• Molecular bases of liver cancer refractoriness to pharmacological treatment.

  2010cites this paper
• Enhancing radiotherapy through a greater understanding of homologous recombination.

  2010cites this paper
• DNA repair gene expression and risk of locoregional relapse in breast cancer patients.

  2010cites this paper
• Experimental approaches for the treatment of malignant gliomas.

  2010cites this paper
• Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair

  2010cites this paper
• - 1In Vitro Effects of Imatinib Mesylate on Radiosensitivity and Chemosensitivity of Breast Cancer Cells

  2010cites this paper
• Overexpressed of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability

  2010cites this paper
• In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells

  2010cites this paper
• Imatinib mesylate in children and adolescents with cancer

  2010cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 527 Combination Therapies Targeting PDGF and VEGF Signaling Pathways in Solid Tumors

  2010cites this paper
• Targeting the DNA damage response in cancer.

  2009cites this paper
• Radiosensitization effect of STI-571 on pancreatic cancer cells in vitro.

  2009cites this paper
• Impact of homologous recombination on individual cellular radiosensitivity.

  2009cites this paper
• Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma

  2009cites this paper
• Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform.

  2009cites this paper
• DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells.

  2009cites this paper
• Detection of c‐Abl kinase‐promoted phosphorylation of Rad51 by specific antibodies reveals that Y54 phosphorylation is dependent on that of Y315

  2009cites this paper